Early onset of rejection in concordant hamster xeno hearts display signs of necrosis, but not apoptosis, correlating to the phosphocreatine concentration

Transplant Immunology

Volumn 12, Issue 1, 2003, Pages 29-40

  Lukes, Daniel J ^a,b   Tivesten, Åsa ^a   Wilton, Jakob ^a,b   Lundgren, Andreas ^a,b   Rakotonirainy, Olivier ^a,b   Kjellström, Christer ^a   Isgaard, Jörgen ^a   Karlsson Parra, Alex ^a   Soussi, Bassam ^a,b   Olausson, Michael ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Concordant; In vitro 31phosphorus magnetic resonance spectroscopy; Necrosis; Rejection; Xenotransplantation

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIBODY; BETA ADENOSINE TRIPHOSPHATE; BIOTIN; CREATINE PHOSPHATE; DNA; EOSIN; HEMATOXYLIN; NUCLEOTIDE DERIVATIVE; OLIGONUCLEOTIDE; PHOSPHATE; PHOSPHORUS 31; UNCLASSIFIED DRUG;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASSAY; BIOCHEMISTRY; CELL INFILTRATION; COLD; COMPLEMENT DEPOSITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DNA EXTRACTION; DNA FLANKING REGION; EXTRACELLULAR SPACE; GEL ELECTROPHORESIS; GRAFT REJECTION; HAMSTER; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART SURGERY; HEART TRANSPLANTATION; IMMUNE RESPONSE; IN VITRO STUDY; ISOGRAFT; MALE; MORPHOLOGY; NECROSIS; NICK END LABELING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RAT; STAINING; XENOTRANSPLANTATION;

EID: 10744219777     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(03)00018-2     Document Type: Article

References (59)

1. Tullius SG, Tilney NL. Both alloantigen-dependent and independent factors influence chronic allograft rejection. Transplantation 1995;59(3):313-318.
2. Bersztel A, Tufveson G, Gannedahl G, Johnsson C. A morphological sequential study of mouse-to-rat cardiac xenografts. Scand J Immunol 1998;48(5):485-490.
3. Johnsson C, Andersson A, Bersztel A, Karlsson-Parra A, Gannedahl G, Tufveson G. Successful retransplantation of mouse-to-rat cardiac xenografts under immunosuppressive monotherapy with cyclosporine. Transplantation 1997;63(5):652-656.
4. Buhler L, Friedman T, Iacomini J, Cooper DK. Xenotransplantation - State of the art - Update. Front Biosci 1999;4:D416-D432.
5. Hammer C, Linke R, Wagner F, Diefenbeck M. Organs from animals for man. Int Arch Allergy Immunol 1998;116(1):5-21.
6. 31P NMR spectroscopy. Surgery Today 1999;29(2):143-148.
7. Fraser CD, Chacko VP, Jacobus WE, et al. Early phosphorus 31 nuclear magnetic resonance bioenergetic changes potentially predict rejection in heterotopic cardiac allografts. J Heart Trans 1990;9(3):197-204.
8. Lukes DJ, Madhu B, Kjellstrom C, et al. Decreasing ratios of phosphocreatine to beta-ATP correlates to progressive acute rejection in a concordant mouse heart to rat xenotransplantation model. Scand J Immunol 2001;53(2):171-175.
9. Lukes DJ, Lundgren A, Wilton J, et al. Singlet oxygen energy illumination during ischemia preserves high energy phosphates in a concordant heart xenotransplantation model. Laser Phys 2003;13(1):1-7.
10. Gao W, Bentley RC, Madden JF, Clavien PA. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology 1998;27(6):1652-1660.
11. Patel T, Gores GJ. Apoptosis in liver transplantation: A mechanism contributing to immune modulation, preservation injury, neoplasia, and viral disease. Liver Transplant Surg 1998;4(1):42-50.
12. Koglin J, Russell ME. Alloimmune-mediated apoptosis: Comparison in mouse models of acute and chronic cardiac rejection. Transplantation 1999;67(6):904-909.
13. Weis M, von Scheidt W. Cardiac allograft vasculopathy: A review. Circulation 1997;96(6):2069-2077.
14. Narula J, Pandey P, Arbustini E, et al. Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy [see comments]. Proc Natl Acad Sci USA 1999;96(14):8144-8149.
15. Miyazaki K. Fine-structural analysis of hyper-acute rejection in cardiac xenotransplantation. Hokkaido Igaku Zasshi 2000;75(5):347-356.
16. Holzknecht ZE, Kuypers KL, Plummer TB, et al. Apoptosis and cellular activation in the pathogenesis of acute vascular rejection. Circ Res 2002;91(12):1135-1141.
17. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: Endogenous activators of dendritic cells. Nat Med 1999;5(11):1249-1255.
18. Saraste A, Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res 2000;45(3):528-537.
19. Saraste A. Morphologic criteria and detection of apoptosis. Herz 1999;24(3):189-195.
20. Didenko VV, Hornsby PJ. Presence of double-strand breaks with single-base 3′ overhangs in cells undergoing apoptosis but not necrosis. J Cell Biol 1996;135(5):1369-1376.
21. Olausson M, Majörnstedt L, Lindholm L, Brynger H. Non-suture organ grafting to the neck vessels in rats. Acta Chirurgica Scand 1984; 150: 463-467.
22. Korsgren O, Wallgren AC, Satake M, Karlsson-Parra A. Xenograft rejection of fetal porcine islet-like cell clusters in the rat: Effects of active and passive immunization. Xenotransplantation 1999;6(4):271-280.
23. Didenko VV, Tunstead JR, Hornsby PJ. Biotin-labeled hairpin oligonucleotides: Probes to detect double-strand breaks in DNA in apoptotic cells. Am J Pathol 1998;152(4):897-902.
24. Steinbruchel DA, Nielsen B, Salomon S, Kemp E. Sequential, morphological, and antidonor antibody analysis in a hamster-to-rat heart transplantation model. Transplant Int 1992;5(1):38-42.
25. Steinbruchel DA. Pathogenesis and mechanisms of graft rejection in concordant xenotransplantation with special reference to hamster-to-rat cardiac transplantation. APMIS Suppl 1996;58:5-45.
26. Ottaviani G, Lavezzi AM, Rossi L, Matturri L. Proliferating cell nuclear antigen (PCNA) and apoptosis in hyperacute and acute myocardial infarction. Eur J Histochem 1999;43(1):7-14.
27. Mallat Z, Fornes P, Costagliola R, et al. Age and gender effects on cardiomyocyte apoptosis in the normal human heart. J Gerontol A Biol Sci Med Sci 2001;56(11):M719-M723.
28. Misao J, Hayakawa Y, Ohno M, Kato S, Fujiwara T, Fujiwara H. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation 1996;94(7):1506-1512.
29. 31P-NMR. Biochim Biophys Acta 1992;1133(2):115-120.
30. 31P MRS study. Am Heart J 1989;118(1):86-91.
31. Hitchins S, Ciesler JM, Dobson GP. 31P NMR quantitation of phosphorus metabolites in rat heart and skeletal muscle in vivo. Am J Physiol Heart Circ Physiol 2001;281(2):H882-H887.
32. Radda GK, Gadian DG, Ross BD. Energy metabolism and cellular pH in normal and pathological conditions. A new look through 31 phosphorus nuclear magnetic resonance. Ciba Foundation Symp 1982;87:36-57.
33. Maulik N, Yoshida T, Das DK. Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis. Free Radic Biol Med 1998;24(5):869-875.
34. Ohno M, Takemura G, Ohno A, et al. Apoptotic' myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: Analysis by immunogold electron microscopy combined with in situ nick end-labeling. Circulation 1998;98(14):1422-1430.
35. Willingham MC. Cytochemical methods for the detection of apoptosis. J Histochem Cytochem 1999;47(9):1101-1110.
36. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992:119(3):493-501.
37. Elsasser A, Suzuki K, Schaper J. Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure. J Mol Cell Cardiol 2000;32(5):711-724.
38. Elsasser A, Suzuki K, Lorenz-Meyer S, Bode C, Schaper J. The role of apoptosis in myocardial ischemia: A critical appraisal. Basic Res Cardiol 2001;96(3):219-226.
39. Chandrasekaran K, Bansal RC, Greenleaf JF, et al. Early recognition of heart transplant rejection by backscatter analysis from serial 2D ECHOs in a heterotopic transplant model. J Heart Transplant 1987;6(1):1-7.
40. Salomon NW, Stinson EB, Griepp RB, Shumway NE. Alterations in total and regional myocardial blood flow during acute rejection of orthotopic canine cardiac allografts. J Thorac Cardiovasc Surg 1978;75(4):542-547.
41. Hauptman PJ, Aranki S, Mudge GH Jr., Couper GS, Loh E. Early cardiac allograft failure after orthotopic heart transplantation. Am Heart J 1994;127(1):179-186.
42. 2 consumption, high-energy phosphates, and substrate uptake in porcine right ventricle. Am J Physiol 1994;266(2 Pt 2):H521-H530.
43. Kammermeier H. Why do cells need phosphocreatine and a phosphocreatine shuttle. J Mol Cell Cardiol 1987;19(1):115-118.
44. 31P-NMR study. Am J Physiol 1991;261(4 Suppl):45-53.
45. Gottlieb RA, Burleson KO, Kloner RA, Babioro BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994;94(4):1621-1628.
46. Nielsen B, Steinbruchel DA, Lillevang ST, Kemp E. Evidence for a primarily humoral rejection mechanism in concordant xenogeneic heart transplantation. A sequential immunohistological study in a hamster-to-rat model. APMIS 1993;101(8):587-594.
47. Nielsen B, Steinbruchel DA, Kemp E. An ultrastructural analysis of concordant and discordant cardiac xenografts in unmodified recipients. A sequential study in rodents with special reference to endothelial cell changes in the microvascular system. APMIS 1994;102(3);197-207.
48. Lucien J, Shimada M, Watzka S, et al. Human serum induces apoptosis of xenogenic cardiomyocytes in vivo and in vitro. Xenotransplantation 2000;7(1):21-30.
49. Bach FH, Ferran C, Hechenleitner P, et al. Accommodation of vascularized xenografts: Expression of 'protective genes' by donor endothelial cells in a host Th2 cytokine environment. J Heart Lung Transplant 1997;16(2):250-255.
50. Miyatake T, Koyamada N, Hancock WW, Soares MP, Bach FH. Survival of accommodated cardiac xenografts upon retransplantation into cyclosporine-treated recipients. Transplantation 1998;65(12):1563-1569.
51. Soares MP, Lin Y, Anrather J, et al. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 1998;4(9):1073-1077.
52. Garnier A, Rossi A, Lavanchy N. Importance of the early alterations of energy metabolism in the induction and the disappearance of ischemic preconditioning in the isolated rat heart. J Mol Cell Cardiol 1996;28(8):1671-1682.
53. Tepper CG, Studzinski GP. Resistance of mitochondrial DNA to degradation characterizes the apoptotic but not the necrotic mode of human leukemia cell death. J Cell Biochem 1993;52(3):352-361.
54. Hasan R, Van Den Bogaerde JB, Wallwork J, White DJ. Evidence that long-term survival of concordant xenografts is achieved by inhibition of antispecies antibody production. Transplantation 1992;54(3):408-413.
55. Marino IR, Celli S, Catena M, et al. Xenotransplantation rejection is antibody-mediated in both sensitized and nonsensitized recipients. J Investigative Surg 1994;7(2):111-122.
56. Hansen S, Holmskov U. Structural aspects of collectins and receptors for collectins. Immunobiology 1998;199(2):165-189.
57. Starzl TE, Rao AS, Murase N, Demetris AJ, Thomson A, Fung JJ. Chimerism and xenotransplantation. New concepts. Surg Clin N Am 1999;79(1):191-205.
58. Hancock WW. Delayed xenograft rejection. World J Surg 1997;21(9):917-923.
59. Matzinger P. Graft tolerance: A duel of two signals. Nat Med 1999;5(6):616-617.